Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Czechia Hungary Poland Portugal Slovakia +1
  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Greece Poland Romania Spain
  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Greece Poland Spain Sweden
  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Germany Hungary Italy The Netherlands +1
  • Study on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

    Not recruiting

    2 1 1 1
    Czechia Germany Hungary Italy The Netherlands Poland +1
  • Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    2 1 1
    Belgium Bulgaria Denmark Germany Greece Italy +4
  • Study on MK-6194 for Adults with Systemic Lupus Erythematosus

    Not recruiting

    4 1
    Investigated Drugs:
    France Italy Poland Spain
  • Study of Belimumab for Children with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Italy Poland Spain